Latest Regulatory Milestones News

Sky Metals has secured a crucial regulatory milestone for its Tallebung tin-silver-tungsten project in NSW, moving into the Environmental Impact Statement phase following the issuance of SEARs by the NSW Department of Planning. The company prepares for imminent resource and feasibility updates that could shape the project’s development trajectory.

Cynata Therapeutics secures a crucial regulatory green light from the EMA’s Paediatric Committee for its CYP-001 treatment in children with acute graft versus host disease, paving the way for sequential adult and paediatric trials in Europe.

Pioneer Minerals has reopened the historic Springfield Mine Road, enabling vehicle access to its North Pine Project in Idaho and slashing exploration costs. This milestone sets the stage for accelerated fieldwork targeting tungsten, gold, and gallium.

ReNerve has inked an exclusive three-year deal with Hong Kong’s Swedish Trading Company to distribute its nerve repair products across a vast and dynamic healthcare region.

Acrux has locked in a milestone-based licensing agreement worth up to AUD 5.4 million for Lenzetto®, targeting the Australian menopause therapy market with regulatory and commercial milestones tied to TGA approval and sales performance.

PolyNovo has completed its pivotal US clinical trial report for NovoSorb BTM and adjusted its FDA Premarket Approval submission timeline to late 2026 to incorporate updated regulatory requirements and additional data.

Vita Resources NL is accelerating exploration across its diverse portfolio, expanding drilling at its Ninnis Gold Project in WA and confirming polymetallic upgrades at its ICE Project in Canada.

EV Resources has cleared a critical regulatory hurdle by obtaining the Change of Use of Soil permit for its Tecomatlán Plant, enabling the final environmental report filing and grid connection application that pave the way for near-term antimony production.

Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.

Jameson Resources has cleared a major environmental hurdle for its Crown Mountain steelmaking coal project, receiving the Section 27 Notice from British Columbia regulators and setting the stage for final application submission in October 2026.

Manhattan Gold Corporation has gained final regulatory approval and a CA$250,000 grant to kick off its maiden 4,000m RC drilling campaign at the Hook Lake Project in Nunavut, Canada.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.